DUBLIN–(BUSINESS WIRE)–The “Bone Growth Stimulators – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Bone Growth Stimulators estimated at US$999.4 Million in the year 2020, is projected to reach a revised size of US$1.27 Billion by 2026, growing at a CAGR of 4.2% over the analysis period. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “G-Protein Coupled Receptors (GPCRs) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for G-Protein Coupled Receptors (GPCRs) estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2026, growing at a CAGR of 5.7% over the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Anti-Doping in Sport – Thematic Research” report has been added to ResearchAndMarkets.com’s offering. An analysis of the problems facing sport with regards to anti-doping and cheating, and an overview of sport’s history with the issue With increased commercialization and an ever-increasing amount of money involved, the stakes in sport have never been higher. … [Read more…]

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Thursday, July 28, 2022. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Second Quarter … [Read more…]

DUBLINDUBLIN–(BUSINESS WIRE)–The “Femtech Market Research Report by Type (Products, Services, and Software), Application, End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Femtech Market size was estimated at USD 24.99 billion in 2021 and expected … [Read more…]

CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of tumours TOKYO–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended that CRYSVITA® (burosumab) be approved … [Read more…]

Innovaccer will participate as a member of the multisector alliance to advance healthcare data sharing, enabling consumers, patients, and caregivers easier access to health information SAN FRANCISCO–(BUSINESS WIRE)–Today, Innovaccer Inc., the Health Cloud company, announced that it has joined the CARIN Alliance (CARIN), a multisector collaborative working to rapidly advance the consumer-directed exchange of health … [Read more…]

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Acquisition–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has acquired a portfolio of branded and generic injectable products from Deer Park, Illinois based-Eton Pharmaceuticals, Inc. (NASDAQ: ETON). The portfolio includes the … [Read more…]

Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company filed a Definitive Information Statement under Section 14C of the Exchange … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Biosimilars Partnering Terms and Agreements 2010 to 2022” report has been added to ResearchAndMarkets.com’s offering. This report is intended to provide the reader with an in-depth understanding and access to Biosimilars trends and structure of deals entered into by leading companies worldwide. The report provides a detailed understanding and analysis of how … [Read more…]